🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

AZIMUTH is our new solution to help patients suffering from heart failure: a new model of care co-designed and co-developed by doctors, patients, industrial and technological partners! linkedin.com/posts/domenico…

#RCM - Vol. 23 No. 8 💥Review Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention Mattia Galli Renzo Laborante Rocco Vergallo FRANCESCO BURZOTTA EHJ Editor-in-Chief Domenico D'Amario #Bleeding #PCI #Complications #antithrombotic therapy Full Text: imrpress.com/journal/RCM/23…

#ESC_HFA clinical trial course in #HF ongoing in the beautiful Sorrento. Outstanding lectures from worldwide experts #Cardiotwitter Gianluigi Savarese Giuseppe Rosano Antonio Cannata'

Molto importante da tutti i punti di vista l'intervento di Domenico D'Amario che ha come tema il progetto di #openinnovation #AI Azimuth, sullo scompenso cardiaco. #digitalhealth Maker Faire Rome - The European Edition live ▶️bit.ly/MFRlive #MFR2022 #MakerFaireRome #branded

How to prevent bleeding in patients undergoing PCI? bit.ly/3VdyY97

Domenico D'Amario presenting talk around microvascular disease and diagnostic pathways -diagnotic workup of inoca needs invasive mx- important role of ACh #GISE Giuseppe Biondi-Zoccai chief Maria Giovanna Lupo Professor Vijay Kunadian Valeria Paradies Minnow Walsh, MD, MACC Ki Park A/Prof Sonya Burgess

Fantastic session discussing the importance and the diagnostic and therapeutic options for INOCA patients. Sici GISE #gise2022 INOCA INTERNATIONAL Hany Ragy Mamas A. Mamas

Deeply pleased and honored to receive the recognition of best oral presentation of the 43rd Italian Society of Interventional Cardiology congress Sici GISE Deep thanks to my mentor and PI of the study Domenico D'Amario and all RIALTO members. #interventionalcardiology #myocardialbridge

Il massiccio della Maiella conta oltre 60 cime che superano i 2000 metri di altezza. Tra queste il Monte Amaro che, con i suoi 2.793 m s.l.m., è la vetta più alta, la seconda di tutto l'Appennino dopo il Corno Grande del Gran Sasso d'Italia. 👉 bit.ly/3CQowgL #Abruzzo

Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis, by Galli et al sciencedirect.com/science/articl… Mattia Galli Davide Capodanno Domenico D'Amario Italo Porto FRANCESCO BURZOTTA Javier Escaned EHJ Editor-in-Chief International Journal of Cardiology

In the world of nuts…. Bicuspid is the new normal

ECPELLA versus #ECMO in #CardiogenicShock – do the potential benefits of this unloading strategy outweigh the increased complications? academic.oup.com/ehjqcco/advanc… #EHJQCCO #CathLab Prof Chris P Gale Diogo Santos Ferreira

Sick and almost tired about Twitter? Already 11 years… #IlMioAnniversarioDiTwitter

#RCM-Special Issue: Antiplatelet Therapy in Cardiovascular Disease (2/5) Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention Mattia Galli Renzo Laborante Rocco Vergallo FRANCESCO BURZOTTA EHJ Editor-in-Chief Domenico D'Amario #PCI #Bleeding Full text imrpress.com/journal/RCM/23…

Take home message for 2023: be careful of adenosine! Renzo Laborante Emiliano Bianchini Attilio Restivo Mattia Galli Andrea Zito Giuseppe Princi Daniele Rodolico Domenico D'Amario EHJ Editor-in-Chief

#HeartFailure2023 comes to the end. 📌We presented data from the Gemelli HF Datamart supporting initiation of 4 pillars at discharge. 🌟Proud also of our work on doses and outcomes, selected among the “Highlights”. Thanks to #HFA_ESC for these amazing days!

In this observational study, Domenico D'Amario Daniele Rodolico et al highlight how many patients with new HFrEF do not receive the 4 pillars of GDMT. Their data suggests those on more classes of GDMT at hospital discharge may have better outcomes. #AHAJournals ahajrnls.org/3Ovj3Sd

#Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in patients undergoing #PCI: the TAPER-S randomised trial bit.ly/47VjbkP Stefan Agewall Felice Gragnano Domenico D'Amario Italo Porto #EHJPharmacotherapy #ESCYoung

Safety and efficacy of early initiation of #SGLT2i after #ACS. An updated meta-analysis just published in #EHJPharmacotherapy bit.ly/3Z5K1G3 EHJ-CVP Editor-in-Chief Felice Gragnano Renzo Laborante Domenico D'Amario Gianluigi Savarese Cardiologia Novara

Fast-track approach for SGLT2-I in patients with ACS 🏎️ #EHJPharmacotherapy 💊 EHJ-CVP Editor-in-Chief 👨‍💼 European Society of Cardiology Journals European Society of Cardiology 📚